◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

NEUROCRINE BIOSCIENCES INC

CIK: 914475 SIC: 2836
$2.86B
Revenue
$478.60M
Net Income
98.18%
Gross Margin
21.64%
Op. Margin
$946.40M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 44 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $805.50M $794.90M $687.50M $572.60M $627.70M $622.10M $590.20M
Revenue Growth % (YoY) 28.3% 27.8% 16.5% nan% nan% nan% nan%
Cost of Revenue $17.60M $14.00M $11.30M $9.20M $9.30M $8.00M $9.20M
+ Gross Profit $787.90M $780.90M $676.20M $563.40M $618.40M $614.10M $581.00M
Gross Margin % 97.8% 98.2% 98.4% 98.4% 98.5% 98.7% 98.4%
Operating Expenses $594.60M $555.90M $541.90M $549.00M $485.70M $438.30M $444.80M
Selling General & Admin $301.80M $291.60M $286.30M $276.50M $287.80M $234.30M $242.00M
+ Operating Income $210.90M $239.00M $145.60M $23.60M $142.00M $183.80M $145.40M
Operating Margin % 26.2% 30.1% 21.2% 4.1% 22.6% 29.5% 24.6%
Interest Expense - - - - - $1.60M $1.60M
Other Income/Expense $28.50M $52.80M $13.90M $-8.90M $20.60M $6.50M $-46.80M
Income Before Tax $239.40M $291.80M $159.50M $14.70M $162.60M $190.30M $98.60M
Income Tax Expense $85.70M $82.30M $52.00M $6.80M $59.50M $60.50M $33.60M
+ Net Income $153.70M $209.50M $107.50M $7.90M $103.10M $129.80M $65.00M
Net Margin % 19.1% 26.4% 15.6% 1.4% 16.4% 20.9% 11.0%
Basic EPS 1.54 2.11 1.09 0.08 1.03 1.28 0.64
Diluted EPS 1.48 2.04 1.06 0.08 1.00 1.24 0.63
Basic Shares Outstanding - 99.4M 99.0M 99.7M -200K 101.1M 100.8M
Diluted Shares Outstanding - 102.5M 101.0M 102.5M -300K 104.3M 103.9M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $713.00M $340.20M $264.00M $194.10M $233.00M $349.10M $139.70M
Accounts Receivable $686.80M $728.00M $595.70M $516.00M $479.10M $481.10M $468.20M
Inventory $69.00M $69.30M $56.90M $59.10M $57.40M $45.80M $42.50M
Other Current Assets $115.80M $68.20M $120.70M $119.30M $112.10M $121.70M $120.20M
Total Current Assets $2.52B $2.16B $1.75B $1.64B $1.72B $1.88B $1.67B
Property Plant & Equipment $89.80M $97.30M $91.70M $87.00M $82.60M $80.00M $80.10M
Intangible Assets - $35.70M $37.20M $36.40M $36.50M $34.50M $33.50M
Other Non-current Assets $59.50M $20.30M $21.60M $15.30M $15.50M $61.60M $57.80M
Total Assets $4.63B $4.27B $3.89B $3.69B $3.72B $3.54B $3.31B
Other Current Liabilities $69.10M $53.70M $56.80M $47.70M $46.10M $37.00M $40.00M
Total Current Liabilities $743.40M $638.00M $546.30M $522.90M $507.70M $429.70M $398.50M
Other Non-current Liabilities $219.70M $195.70M $210.10M $181.60M $166.20M $135.00M $141.10M
Total Liabilities $1.38B $1.26B $1.20B $1.15B $1.13B $816.10M $795.80M
Common Stock $100.00K $100.00K $100.00K $100.00K $100.00K $100.00K $100.00K
Retained Earnings $447.70M $294.00M $84.50M $-5.30M $29.20M $81.10M $-48.70M
Total Stockholders Equity $3.25B $3.00B $2.69B $2.54B $2.59B $2.72B $2.51B
Total Liabilities & Equity $4.63B $4.27B $3.89B $3.69B $3.72B $3.54B $3.31B
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $153.70M $209.50M $107.50M $7.90M $103.10M $129.80M $108.40M
Stock-based Compensation $58.60M $159.30M $105.60M $52.80M $66.40M $129.10M $87.60M
Change in Receivables $-38.40M $248.90M $116.60M $36.90M $-2.00M $41.80M $28.90M
Change in Inventory $3.40M $11.90M $-400.00K $1.70M $11.60M $7.50M $4.20M
Operating Cash Flow $388.40M $394.30M $166.80M $64.80M $242.50M $352.90M $194.90M
Capital Expenditure $-2.40M $36.40M $23.20M $10.70M $7.30M $30.90M $22.80M
Investing Cash Flow $-52.90M $-211.50M $-14.80M $14.20M $-68.30M $-58.50M $-83.20M
Stock Issued $37.30M $92.10M $46.50M $32.10M $10.00M $112.10M $85.70M
Stock Repurchased - $167.70M $167.70M $150.00M $300.00M - -
Financing Cash Flow $37.30M $-75.60M $-121.20M $-117.90M $-290.00M $-196.70M $-223.10M
Net Change in Cash $372.80M $107.20M $31.00M $-38.90M $-116.10M $98.00M $-111.40M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $794.90M - $2.06B -
Cost of Revenue $14.00M - $34.50M -
Operating Expenses $555.90M - $1.65B -
Selling General & Admin $291.60M - $854.40M -
Operating Income $239.00M - $408.20M -
Interest Expense - - - -
Other Income/Expense $52.80M - $57.80M -
Income Before Tax $291.80M - $466.00M -
Income Tax Expense $82.30M - $141.10M -
Net Income $209.50M - $324.90M -
Basic EPS 2.11 - 3.27 -
Diluted EPS 2.04 - 3.19 -
Basic Shares Outstanding $99.40M - $99.30M -
Diluted Shares Outstanding $102.50M - $102.00M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $340.20M $233.00M
Accounts Receivable $728.00M $479.10M
Inventory $69.30M $57.40M
Other Current Assets $68.20M $63.60M
Total Current Assets $2.16B $1.72B
Property Plant & Equipment $97.30M $82.60M
Intangible Assets $35.70M $36.50M
Other Non-current Assets $20.30M $15.50M
Total Assets $4.27B $3.72B
Other Current Liabilities $53.70M $46.10M
Total Current Liabilities $638.00M $507.70M
Other Non-current Liabilities $195.70M $166.20M
Total Liabilities $1.26B $1.13B
Common Stock $100.00K $100.00K
Retained Earnings $294.00M $29.20M
Total Stockholders Equity $3.00B $2.59B
Total Liabilities & Equity $4.27B $3.72B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $209.50M - $324.90M -
Stock-based Compensation - - $159.30M -
Change in Receivables - - $248.90M -
Change in Inventory - - $11.90M -
Operating Cash Flow - - $394.30M -
Capital Expenditure - - $36.40M -
Investing Cash Flow - - $-211.50M -
Stock Issued - - $92.10M -
Stock Repurchased - - $167.70M -
Financing Cash Flow - - $-75.60M -
Net Change in Cash - - $107.20M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...